All drugs that target Interleukin-17A — marketed and clinical-stage.
Marketed (3)
Bimzelx · Ucb Japan Co., Ltd. · Immunology Bimzelx works by binding to interleukin-17A, a protein that promotes inflammation, to reduce symptoms of psoriasis.
Cosentyx · Janssen Research & Development, LLC · Immunology